< 0 1 0 1 O
40 2 4 2 4 B-upper_bound
% 4 5 4 5 I-upper_bound
by 6 8 6 8 O
Multi 9 14 9 14 B-clinical_variable
Gated 15 20 15 20 I-clinical_variable
Acquisition 21 32 21 32 I-clinical_variable
Scan 33 37 33 37 I-clinical_variable
( 38 39 38 39 I-clinical_variable
MUGA 39 43 39 43 I-clinical_variable
) 43 44 43 44 I-clinical_variable

< 0 1 45 46 O
50 2 4 47 49 B-upper_bound
% 4 5 49 50 I-upper_bound
by 6 8 51 53 O
echocardiogram 9 23 54 68 B-treatment
and/or 24 30 69 75 O
MRI 31 34 76 79 B-treatment

A 0 1 80 81 O
known 2 7 82 87 O
history 8 15 88 95 O
of 16 18 96 98 O
sustained 19 28 99 108 B-chronic_disease
ventricular 29 40 109 120 I-chronic_disease
tachycardia 41 52 121 132 I-chronic_disease
( 53 54 133 134 I-chronic_disease
VT 54 56 134 136 I-chronic_disease
) 56 57 136 137 I-chronic_disease
, 57 58 137 138 O
ventricular 59 70 139 150 B-chronic_disease
fibrillation 71 83 151 163 I-chronic_disease
( 84 85 164 165 I-chronic_disease
VF 85 87 165 167 I-chronic_disease
) 87 88 167 168 I-chronic_disease
, 88 89 168 169 O
Torsade 90 97 170 177 B-chronic_disease
de 98 100 178 180 I-chronic_disease
Pointes 101 108 181 188 I-chronic_disease

Alanine 0 7 189 196 B-clinical_variable
transaminase 8 20 197 209 I-clinical_variable
( 21 22 210 211 I-clinical_variable
ALT 22 25 211 214 I-clinical_variable
) 25 26 214 215 I-clinical_variable
( 27 28 216 217 I-clinical_variable
SPGT 28 32 217 221 I-clinical_variable
) 32 33 221 222 I-clinical_variable
≤ 34 35 223 224 O
2.5 36 39 225 228 B-upper_bound
x 40 41 229 230 I-upper_bound
IULN 42 46 231 235 I-upper_bound

All 0 3 236 239 O
patients 4 12 240 248 O
should 13 19 249 255 O
have 20 24 256 260 O
received 25 33 261 269 O
at 34 36 270 272 O
least 37 42 273 278 O
one 43 46 279 282 B-lower_bound
line 47 51 283 287 O
of 52 54 288 290 O
chemotherapy 55 67 291 303 B-treatment
in 68 70 304 306 O
either 71 77 307 313 O
the 78 81 314 317 O
advanced 82 90 318 326 O
or 91 93 327 329 O
adjuvant 94 102 330 338 O
setting 103 110 339 346 O
and 111 114 347 350 O
hormonal 115 123 351 359 B-treatment
therapy 124 131 360 367 I-treatment
( 132 133 368 369 O
where 133 138 369 374 O
appropriate 139 150 375 386 O
) 150 151 386 387 O

An 0 2 388 390 O
ECG 3 6 391 394 B-treatment
recorded 7 15 395 403 O
at 16 18 404 406 O
screening 19 28 407 416 O
showing 29 36 417 424 O
evidence 37 45 425 433 O
of 46 48 434 436 O
cardiac 49 56 437 444 B-chronic_disease
ischemia 57 65 445 453 I-chronic_disease

Any 0 3 454 457 O
cardiac 4 11 458 465 B-chronic_disease
arrhythmia 12 22 466 476 I-chronic_disease
requiring 23 32 477 486 O
an 33 35 487 489 O
anti 36 40 490 494 B-treatment
- 40 41 494 495 I-treatment
arrhythmic 41 51 495 505 I-treatment
medication 52 62 506 516 I-treatment

Breast 0 6 517 523 B-cancer
cancer 7 13 524 530 I-cancer
that 14 18 531 535 O
is 19 21 536 538 O
either 22 28 539 545 O
stage 29 34 546 551 B-chronic_disease
III 35 38 552 555 I-chronic_disease
disease 39 46 556 563 I-chronic_disease
not 47 50 564 567 O
amenable 51 59 568 576 O
to 60 62 577 579 O
curative 63 71 580 588 B-treatment
therapy 72 79 589 596 I-treatment
or 80 82 597 599 O
stage 83 88 600 605 O
IV 89 91 606 608 O

Concomitant 0 11 609 620 O
use 12 15 621 624 O
of 16 18 625 627 O
CYP3A4 19 25 628 634 B-treatment
inhibitors 26 36 635 645 I-treatment

Confirmed 0 9 646 655 O
germline 10 18 656 664 O
BRCA1 19 24 665 670 O
or 25 27 671 673 O
BRCA2 28 33 674 679 O
mutation 34 42 680 688 O
, 42 43 688 689 O
regardless 44 54 690 700 O
of 55 57 701 703 O
subtype 58 65 704 711 O
of 66 68 712 714 O
breast 69 75 715 721 B-cancer
cancer 76 82 722 728 I-cancer

Congenital 0 10 729 739 B-chronic_disease
long 11 15 740 744 I-chronic_disease
QT 16 18 745 747 I-chronic_disease
syndrome 19 27 748 756 I-chronic_disease

Congestive 0 10 757 767 B-chronic_disease
heart 11 16 768 773 I-chronic_disease
failure 17 24 774 781 I-chronic_disease
( 25 26 782 783 I-chronic_disease
CHF 26 29 783 786 I-chronic_disease
) 29 30 786 787 I-chronic_disease
that 31 35 788 792 O
meets 36 41 793 798 O
New 42 45 799 802 B-clinical_variable
York 46 50 803 807 I-clinical_variable
Heart 51 56 808 813 I-clinical_variable
Association 57 68 814 825 I-clinical_variable
( 69 70 826 827 I-clinical_variable
NYHA 70 74 827 831 I-clinical_variable
) 74 75 831 832 I-clinical_variable
Class 76 81 833 838 B-lower_bound
II 82 84 839 841 I-lower_bound
to 85 87 842 844 O
IV 88 90 845 847 B-upper_bound
definitions 91 102 848 859 O
and/or 103 109 860 866 O
ejection 110 118 867 875 O
fraction 119 127 876 884 O

Corrected 0 9 885 894 B-clinical_variable
QT 10 12 895 897 I-clinical_variable
interval 13 21 898 906 I-clinical_variable
( 22 23 907 908 I-clinical_variable
QTc 23 26 908 911 I-clinical_variable
) 26 27 911 912 I-clinical_variable
interval 28 36 913 921 I-clinical_variable
≥ 37 38 922 923 O
500 39 42 924 927 B-lower_bound
ms 43 45 928 930 I-lower_bound
on 46 48 931 933 O
the 49 52 934 937 O
screening 53 62 938 947 O
ECG 63 66 948 951 B-clinical_variable
( 67 68 952 953 O
using 68 73 953 958 O
the 74 77 959 962 O
corrected 78 87 963 972 B-clinical_variable
QT 88 90 973 975 I-clinical_variable
interval 91 99 976 984 I-clinical_variable
to 100 102 985 987 I-clinical_variable
Fridericia 103 113 988 998 I-clinical_variable
's 113 115 998 1000 I-clinical_variable
formula 116 123 1001 1008 I-clinical_variable
[ 124 125 1009 1010 I-clinical_variable
QTcF 125 129 1010 1014 I-clinical_variable
] 129 130 1014 1015 I-clinical_variable
) 130 131 1015 1016 O

Eastern 0 7 1017 1024 B-clinical_variable
Oncology 8 16 1025 1033 I-clinical_variable
Cooperative 17 28 1034 1045 I-clinical_variable
Group 29 34 1046 1051 I-clinical_variable
( 35 36 1052 1053 I-clinical_variable
ECOG 36 40 1053 1057 I-clinical_variable
) 40 41 1057 1058 I-clinical_variable
Performance 42 53 1059 1070 I-clinical_variable
status 54 60 1071 1077 I-clinical_variable
of 61 63 1078 1080 O
≥ 64 65 1081 1082 O
2 66 67 1083 1084 B-lower_bound

Have 0 4 1085 1089 O
at 5 7 1090 1092 O
least 8 13 1093 1098 O
one 14 17 1099 1102 B-lower_bound
measurable 18 28 1103 1113 O
lesion 29 35 1114 1120 B-clinical_variable
of 36 38 1121 1123 O
≥ 39 40 1124 1125 O
2 41 42 1126 1127 B-lower_bound
cm 43 45 1128 1130 I-lower_bound
by 46 48 1131 1133 O
conventional 49 61 1134 1146 O
methods 62 69 1147 1154 O

Histologically 0 14 1155 1169 O
proven 15 21 1170 1176 O
TNBC 22 26 1177 1181 B-cancer

Hypertrophic 0 12 1182 1194 B-chronic_disease
cardiomegaly 13 25 1195 1207 I-chronic_disease
or 26 28 1208 1210 O
restrictive 29 40 1211 1222 B-chronic_disease
cardiomyopathy 41 55 1223 1237 I-chronic_disease
from 56 60 1238 1242 O
prior 61 66 1243 1248 B-treatment
treatment 67 76 1249 1258 I-treatment
or 77 79 1259 1261 O
other 80 85 1262 1267 O
causes 86 92 1268 1274 O

IV 0 2 1275 1277 B-treatment
bisphosphonate 3 17 1278 1292 I-treatment
and 18 21 1293 1296 O
denosumab 22 31 1297 1306 B-treatment
for 32 35 1307 1310 O
bony 36 40 1311 1315 O
metastatic 41 51 1316 1326 B-cancer
disease 52 59 1327 1334 I-cancer
is 60 62 1335 1337 O
allowed 63 70 1338 1345 O

Inhaled 0 7 1346 1353 B-treatment
or 8 10 1354 1356 O
topical 11 18 1357 1364 B-treatment
steroids 19 27 1365 1373 I-treatment
and 28 31 1374 1377 O
adrenal 32 39 1378 1385 B-treatment
replacement 40 51 1386 1397 I-treatment
doses 52 57 1398 1403 O
> 58 59 1404 1405 O
10 60 62 1406 1408 B-lower_bound
mg 63 65 1409 1411 I-lower_bound
daily 66 71 1412 1417 O
prednisone 72 82 1418 1428 B-treatment
equivalents 83 94 1429 1440 O
are 95 98 1441 1444 O
permitted 99 108 1445 1454 O
in 109 111 1455 1457 O
the 112 115 1458 1461 O
absence 116 123 1462 1469 O
of 124 126 1470 1472 O
active 127 133 1473 1479 O
autoimmune 134 144 1480 1490 B-chronic_disease
disease 145 152 1491 1498 I-chronic_disease

International 0 13 1499 1512 B-clinical_variable
Normalized 14 24 1513 1523 I-clinical_variable
Ratio 25 30 1524 1529 I-clinical_variable
( 31 32 1530 1531 I-clinical_variable
INR 32 35 1531 1534 I-clinical_variable
) 35 36 1534 1535 I-clinical_variable
≤ 37 38 1536 1537 O
1.5 39 42 1538 1541 B-upper_bound

Myocardial 0 10 1542 1552 B-chronic_disease
infarction 11 21 1553 1563 I-chronic_disease
within 22 28 1564 1570 O
6 29 30 1571 1572 B-upper_bound
months 31 37 1573 1579 I-upper_bound
of 38 40 1580 1582 O
Cycle 41 46 1583 1588 O
1 47 48 1589 1590 O
Day 49 52 1591 1594 O
1 53 54 1595 1596 O
( 55 56 1597 1598 O
C1D1 56 60 1598 1602 O
) 60 61 1602 1603 O

No 0 2 1604 1606 O
limit 3 8 1607 1612 O
to 9 11 1613 1615 O
prior 12 17 1616 1621 B-treatment
therapy 18 25 1622 1629 I-treatment
for 26 29 1630 1633 O
metastatic 30 40 1634 1644 B-cancer
breast 41 47 1645 1651 I-cancer
cancer 48 54 1652 1658 I-cancer

Other 0 5 1659 1664 O
medical 6 13 1665 1672 B-chronic_disease
or 14 16 1673 1675 O
psychiatric 17 28 1676 1687 B-chronic_disease
disorder 29 37 1688 1696 I-chronic_disease
placing 38 45 1697 1704 O
the 46 49 1705 1708 O
subject 50 57 1709 1716 O
at 58 60 1717 1719 O
undue 61 66 1720 1725 O
risk 67 71 1726 1730 O
for 72 75 1731 1734 O
treatment 76 85 1735 1744 B-treatment
complications 86 99 1745 1758 O

Other 0 5 1759 1764 O
significant 6 17 1765 1776 O
ECG 18 21 1777 1780 B-chronic_disease
abnormalities 22 35 1781 1794 I-chronic_disease
including 36 45 1795 1804 O
2nd 46 49 1805 1808 B-chronic_disease
degree 50 56 1809 1815 I-chronic_disease
atrio 57 62 1816 1821 I-chronic_disease
- 62 63 1821 1822 I-chronic_disease
ventricular 63 74 1822 1833 I-chronic_disease
( 75 76 1834 1835 I-chronic_disease
AV 76 78 1835 1837 I-chronic_disease
) 78 79 1837 1838 I-chronic_disease
block 80 85 1839 1844 I-chronic_disease
type 86 90 1845 1849 I-chronic_disease
II 91 93 1850 1852 I-chronic_disease
, 93 94 1852 1853 O
3rd 95 98 1854 1857 B-chronic_disease
degree 99 105 1858 1864 I-chronic_disease
AV 106 108 1865 1867 I-chronic_disease
block 109 114 1868 1873 I-chronic_disease
, 114 115 1873 1874 O
or 116 118 1875 1877 O
bradycardia 119 130 1878 1889 B-chronic_disease

Participants 0 12 1890 1902 O
who 13 16 1903 1906 O
have 17 21 1907 1911 O
previously 22 32 1912 1922 O
been 33 37 1923 1927 O
treated 38 45 1928 1935 O
with 46 50 1936 1940 O
endocrine 51 60 1941 1950 B-treatment
therapy 61 68 1951 1958 I-treatment
only 69 73 1959 1963 O
, 73 74 1963 1964 O
and 75 78 1965 1968 O
later 79 84 1969 1974 O
develop 85 92 1975 1982 O
triple 93 99 1983 1989 B-cancer
negative 100 108 1990 1998 I-cancer
disease 109 116 1999 2006 I-cancer
are 117 120 2007 2010 O
eligible 121 129 2011 2019 O
as 130 132 2020 2022 O
long 133 137 2023 2027 O
as 138 140 2028 2030 O
they 141 145 2031 2035 O
have 146 150 2036 2040 O
had 151 154 2041 2044 O
one 155 158 2045 2048 O
line 159 163 2049 2053 O
of 164 166 2054 2056 O
chemotherapy 167 179 2057 2069 B-treatment
in 180 182 2070 2072 O
either 183 189 2073 2079 O
the 190 193 2080 2083 O
advanced 194 202 2084 2092 O
or 203 205 2093 2095 O
adjuvant 206 214 2096 2104 B-treatment
setting 215 222 2105 2112 I-treatment

Radiation 0 9 2113 2122 B-treatment
to 10 12 2123 2125 O
bony 13 17 2126 2130 O
metastases 18 28 2131 2141 B-cancer
is 29 31 2142 2144 O
allowed 32 39 2145 2152 O
≥ 40 41 2153 2154 O
14 42 44 2155 2157 B-lower_bound
days 45 49 2158 2162 I-lower_bound
before 50 56 2163 2169 O
starting 57 65 2170 2178 O
study 66 71 2179 2184 B-treatment
treatment 72 81 2185 2194 I-treatment

ST 0 2 2195 2197 B-clinical_variable
depression 3 13 2198 2208 I-clinical_variable
of 14 16 2209 2211 O
≥ 17 18 2212 2213 O
2 19 20 2214 2215 B-lower_bound
mm 21 23 2216 2218 I-lower_bound
, 23 24 2218 2219 O
measured 25 33 2220 2228 O
from 34 38 2229 2233 O
isoelectric 39 50 2234 2245 O
line 51 55 2246 2250 O
to 56 58 2251 2253 O
the 59 62 2254 2257 O
ST 63 65 2258 2260 O
segment 66 73 2261 2268 O

Serum 0 5 2269 2274 B-clinical_variable
creatinine 6 16 2275 2285 I-clinical_variable
≤ 17 18 2286 2287 O
1.5 19 22 2288 2291 B-upper_bound
x 23 24 2292 2293 I-upper_bound
IULN 25 29 2294 2298 I-upper_bound

Serum 0 5 2299 2304 B-clinical_variable
magnesium 6 15 2305 2314 I-clinical_variable
> 16 17 2315 2316 O
1.8 17 20 2316 2319 B-lower_bound
mg 21 23 2320 2322 I-lower_bound
/ 23 24 2322 2323 I-lower_bound
dL 24 26 2323 2325 I-lower_bound

Serum 0 5 2326 2331 B-clinical_variable
potassium 6 15 2332 2341 I-clinical_variable
> 16 17 2342 2343 O
3.8 18 21 2344 2347 B-lower_bound
mmol 22 26 2348 2352 I-lower_bound
/ 26 27 2352 2353 I-lower_bound
L 27 28 2353 2354 I-lower_bound

Subject 0 7 2355 2362 O
has 8 11 2363 2366 O
a 12 13 2367 2368 O
concurrent 14 24 2369 2379 O
malignancy 25 35 2380 2390 B-cancer

Subject 0 7 2391 2398 O
has 8 11 2399 2402 O
a 12 13 2403 2404 O
known 14 19 2405 2410 O
hypersensitivity 20 36 2411 2427 O
to 37 39 2428 2430 O
any 40 43 2431 2434 O
of 44 46 2435 2437 O
the 47 50 2438 2441 O
excipients 51 61 2442 2452 O
of 62 64 2453 2455 O
nivolumab 65 74 2456 2465 B-allergy_name
, 74 75 2465 2466 O
cisplatin 76 85 2467 2476 B-allergy_name
or 86 88 2477 2479 O
romidepsin 89 99 2480 2490 B-allergy_name

Subject 0 7 2491 2498 O
has 8 11 2499 2502 O
active 12 18 2503 2509 O
cardiac 19 26 2510 2517 B-chronic_disease
disease 27 34 2518 2525 I-chronic_disease
or 35 37 2526 2528 O
a 38 39 2529 2530 O
history 40 47 2531 2538 O
of 48 50 2539 2541 O
cardiac 51 58 2542 2549 B-chronic_disease
dysfunction 59 70 2550 2561 I-chronic_disease

Subject 0 7 2562 2569 O
has 8 11 2570 2573 O
active 12 18 2574 2580 B-chronic_disease
, 18 19 2580 2581 O
uncontrolled 20 32 2582 2594 B-chronic_disease
infection 33 42 2595 2604 I-chronic_disease

Subject 0 7 2605 2612 O
has 8 11 2613 2616 O
had 12 15 2617 2620 O
major 16 21 2621 2626 B-treatment
surgery 22 29 2627 2634 I-treatment

Subject 0 7 2635 2642 O
has 8 11 2643 2646 O
inflammatory 12 24 2647 2659 B-cancer
breast 25 31 2660 2666 I-cancer
cancer 32 38 2667 2673 I-cancer

Subject 0 7 2674 2681 O
has 8 11 2682 2685 O
known 12 17 2686 2691 O
history 18 25 2692 2699 O
of 26 28 2700 2702 O
testing 29 36 2703 2710 O
positive 37 45 2711 2719 O
for 46 49 2720 2723 O
HIV 50 53 2724 2727 B-chronic_disease
or 54 56 2728 2730 O
AIDS 57 61 2731 2735 B-chronic_disease

Subject 0 7 2736 2743 O
has 8 11 2744 2747 O
previously 12 22 2748 2758 O
been 23 27 2759 2763 O
treated 28 35 2764 2771 O
with 36 40 2772 2776 O
a 41 42 2777 2778 O
Histone 43 50 2779 2786 B-treatment
deacetylases 51 63 2787 2799 I-treatment
( 64 65 2800 2801 I-treatment
HDAC 65 69 2801 2805 I-treatment
) 69 70 2805 2806 I-treatment
inhibitor 71 80 2807 2816 I-treatment
, 80 81 2816 2817 O
PD-1 82 86 2818 2822 B-treatment
inhibitor 87 96 2823 2832 I-treatment
, 96 97 2832 2833 O
PD 98 100 2834 2836 B-treatment
- 100 101 2836 2837 I-treatment
L1 101 103 2837 2839 I-treatment
inhibitor 104 113 2840 2849 I-treatment
, 113 114 2849 2850 O
PD 115 117 2851 2853 B-treatment
- 117 118 2853 2854 I-treatment
L2 118 120 2854 2856 I-treatment
inhibitor 121 130 2857 2866 I-treatment
, 130 131 2866 2867 O
CTLA-4 132 138 2868 2874 B-treatment
inhibitor 139 148 2875 2884 I-treatment

Subject 0 7 2885 2892 O
has 8 11 2893 2896 O
received 12 20 2897 2905 O
any 21 24 2906 2909 O
anti 25 29 2910 2914 B-treatment
- 29 30 2914 2915 I-treatment
cancer 30 36 2915 2921 I-treatment
therapy 37 44 2922 2929 I-treatment
including 45 54 2930 2939 O
chemotherapy 55 67 2940 2952 B-treatment
, 67 68 2952 2953 O
immunotherapy 69 82 2954 2967 B-treatment
, 82 83 2967 2968 O
biologic 84 92 2969 2977 B-treatment
, 92 93 2977 2978 O
targeted 94 102 2979 2987 B-treatment
therapy 103 110 2988 2995 I-treatment
, 110 111 2995 2996 O
or 112 114 2997 2999 O
any 115 118 3000 3003 O
investigational 119 134 3004 3019 B-treatment
therapy 135 142 3020 3027 I-treatment

Subject 0 7 3028 3035 O
is 8 10 3036 3038 O
currently 11 20 3039 3048 O
receiving 21 30 3049 3058 O
or 31 33 3059 3061 O
has 34 37 3062 3065 O
received 38 46 3066 3074 O
systemic 47 55 3075 3083 B-treatment
corticosteroids 56 71 3084 3099 I-treatment

Subject 0 7 3100 3107 O
is 8 10 3108 3110 O
currently 11 20 3111 3120 O
receiving 21 30 3121 3130 O
treatment 31 40 3131 3140 B-treatment
with 41 45 3141 3145 I-treatment
drugs 46 51 3146 3151 I-treatment
known 52 57 3152 3157 I-treatment
to 58 60 3158 3160 I-treatment
be 61 63 3161 3163 I-treatment
moderate 64 72 3164 3172 I-treatment
or 73 75 3173 3175 I-treatment
strong 76 82 3176 3182 I-treatment
inhibitors 83 93 3183 3193 I-treatment
or 94 96 3194 3196 I-treatment
inducers 97 105 3197 3205 I-treatment
of 106 108 3206 3208 I-treatment
isoenzyme 109 118 3209 3218 I-treatment
CYP3A 119 124 3219 3224 I-treatment

Subject 0 7 3225 3232 O
is 8 10 3233 3235 O
currently 11 20 3236 3245 O
receiving 21 30 3246 3255 O
warfarin 31 39 3256 3264 B-treatment
or 40 42 3265 3267 O
other 43 48 3268 3273 O
coumarin 49 57 3274 3282 B-treatment
derived 58 65 3283 3290 O
anti 66 70 3291 3295 B-treatment
- 70 71 3295 3296 I-treatment
coagulant 71 80 3296 3305 I-treatment
for 81 84 3306 3309 O
treatment 85 94 3310 3319 B-treatment

Subject 0 7 3320 3327 O
is 8 10 3328 3330 O
pregnant 11 19 3331 3339 B-pregnancy

Subject 0 7 3340 3347 O
tests 8 13 3348 3353 O
positive 14 22 3354 3362 O
for 23 26 3363 3366 O
hepatitis 27 36 3367 3376 B-chronic_disease
B 37 38 3377 3378 I-chronic_disease
or 39 41 3379 3381 I-chronic_disease
C 42 43 3382 3383 I-chronic_disease
indicating 44 54 3384 3394 O
acute 55 60 3395 3400 O
or 61 63 3401 3403 O
chronic 64 71 3404 3411 B-chronic_disease
infection 72 81 3412 3421 I-chronic_disease

Subjects 0 8 3422 3430 O
taking 9 15 3431 3437 O
drugs 16 21 3438 3443 O
leading 22 29 3444 3451 O
to 30 32 3452 3454 O
significant 33 44 3455 3466 O
QT 45 47 3467 3469 B-clinical_variable
prolongation 48 60 3470 3482 I-clinical_variable

Subjects 0 8 3483 3491 O
who 9 12 3492 3495 O
have 13 17 3496 3500 O
not 18 21 3501 3504 O
recovered 22 31 3505 3514 O
to 32 34 3515 3517 O
within 35 41 3518 3524 O
one 42 45 3525 3528 B-upper_bound
grade 46 51 3529 3534 I-upper_bound
level 52 57 3535 3540 I-upper_bound
( 58 59 3541 3542 O
not 59 62 3542 3545 O
to 63 65 3546 3548 O
exceed 66 72 3549 3555 O
Grade 73 78 3556 3561 B-upper_bound
2 79 80 3562 3563 I-upper_bound
) 80 81 3563 3564 O
of 82 84 3565 3567 O
their 85 90 3568 3573 O
baseline 91 99 3574 3582 O
following 100 109 3583 3592 O
a 110 111 3593 3594 O
significant 112 123 3595 3606 O
adverse 124 131 3607 3614 O
event 132 137 3615 3620 O
or 138 140 3621 3623 O
toxicity 141 149 3624 3632 O
attributed 150 160 3633 3643 O
to 161 163 3644 3646 O
prior 164 169 3647 3652 B-treatment
treatment 170 179 3653 3662 I-treatment

Subjects 0 8 3663 3671 O
with 9 13 3672 3676 O
baseline 14 22 3677 3685 B-clinical_variable
peripheral 23 33 3686 3696 I-clinical_variable
neuropathy 34 44 3697 3707 I-clinical_variable
that 45 49 3708 3712 O
exceeds 50 57 3713 3720 O
Grade 58 63 3721 3726 B-lower_bound
1 64 65 3727 3728 I-lower_bound

Subjects 0 8 3729 3737 O
with 9 13 3738 3742 O
previously 14 24 3743 3753 O
treated 25 32 3754 3761 O
brain 33 38 3762 3767 B-cancer
metastasis 39 49 3768 3778 I-cancer
who 50 53 3779 3782 O
are 54 57 3783 3786 O
free 58 62 3787 3791 O
of 63 65 3792 3794 O
central 66 73 3795 3802 O
nervous 74 81 3803 3810 O
system 82 88 3811 3817 O
( 89 90 3818 3819 O
CNS 90 93 3819 3822 O
) 93 94 3822 3823 O
symptoms 95 103 3824 3832 O

Symptomatic 0 11 3833 3844 O
coronary 12 20 3845 3853 B-chronic_disease
artery 21 27 3854 3860 I-chronic_disease
disease 28 35 3861 3868 I-chronic_disease
( 36 37 3869 3870 I-chronic_disease
CAD 37 40 3870 3873 I-chronic_disease
) 40 41 3873 3874 I-chronic_disease

The 0 3 3875 3878 O
subject 4 11 3879 3886 O
must 12 16 3887 3891 O
have 17 21 3892 3896 O
discontinued 22 34 3897 3909 O
strong 35 41 3910 3916 B-treatment
inducers 42 50 3917 3925 I-treatment
for 51 54 3926 3929 O
at 55 57 3930 3932 O
least 58 63 3933 3938 O
one 64 67 3939 3942 B-lower_bound
week 68 72 3943 3947 I-lower_bound
and 73 76 3948 3951 O
must 77 81 3952 3956 O
have 82 86 3957 3961 O
discontinued 87 99 3962 3974 O
strong 100 106 3975 3981 B-treatment
inhibitors 107 117 3982 3992 I-treatment
before 118 124 3993 3999 O
the 125 128 4000 4003 O
start 129 134 4004 4009 O
of 135 137 4010 4012 O
treatment 138 147 4013 4022 B-treatment

Women 0 5 4023 4028 B-gender
of 6 8 4029 4031 O
child 9 14 4032 4037 O
bearing 15 22 4038 4045 O
potential 23 32 4046 4055 O

absolute 0 8 4056 4064 B-clinical_variable
neutrophil 9 19 4065 4075 I-clinical_variable
count 20 25 4076 4081 I-clinical_variable
≥ 26 27 4082 4083 O
1,500 28 33 4084 4089 B-lower_bound
/ 33 34 4089 4090 I-lower_bound
uL 34 36 4090 4092 I-lower_bound
( 37 38 4093 4094 I-lower_bound
microliter 38 48 4094 4104 I-lower_bound
) 48 49 4104 4105 I-lower_bound

are 0 3 4106 4109 O
≥ 4 5 4110 4111 O
14 6 8 4112 4114 B-lower_bound
days 9 13 4115 4119 I-lower_bound
from 14 18 4120 4124 O
treatment 19 28 4125 4134 B-treatment
of 29 31 4135 4137 O
brain 32 37 4138 4143 B-cancer
metastasis 38 48 4144 4154 I-cancer
are 49 52 4155 4158 O
eligible 53 61 4159 4167 O

cardiac 0 7 4168 4175 B-chronic_disease
arrest 8 14 4176 4182 I-chronic_disease
unless 15 21 4183 4189 O
currently 22 31 4190 4199 O
addressed 32 41 4200 4209 O
with 42 46 4210 4214 O
an 47 49 4215 4217 O
automatic 50 59 4218 4227 B-treatment
implantable 60 71 4228 4239 I-treatment
cardioverter 72 84 4240 4252 I-treatment
defibrillator 85 98 4253 4266 I-treatment
( 99 100 4267 4268 I-treatment
AICD 100 104 4268 4272 I-treatment
) 104 105 4272 4273 I-treatment

for 0 3 4274 4277 O
at 4 6 4278 4280 O
least 7 12 4281 4286 O
one 13 16 4287 4290 B-lower_bound
month 17 22 4291 4296 I-lower_bound

hemoglobin 0 10 4297 4307 B-clinical_variable
> 11 12 4308 4309 O
9 13 14 4310 4311 B-lower_bound
g 15 16 4312 4313 I-lower_bound
/ 16 17 4313 4314 I-lower_bound
dL 17 19 4314 4316 I-lower_bound
( 20 21 4317 4318 O
which 21 26 4318 4323 O
may 27 30 4324 4327 O
be 31 33 4328 4330 O
reached 34 41 4331 4338 O
by 42 44 4339 4341 O
transfusion 45 56 4342 4353 B-treatment
) 56 57 4353 4354 O

herapy 0 6 4355 4361 B-treatment
with 7 11 4362 4366 I-treatment
heparin 12 19 4367 4374 I-treatment
, 19 20 4374 4375 O
low 21 24 4376 4379 B-treatment
molecular 25 34 4380 4389 I-treatment
weight 35 41 4390 4396 I-treatment
heparin 42 49 4397 4404 I-treatment
( 50 51 4405 4406 I-treatment
LMWH 51 55 4406 4410 I-treatment
) 55 56 4410 4411 I-treatment
, 56 57 4411 4412 O
Factor 58 64 4413 4419 B-treatment
Xa 65 67 4420 4422 I-treatment
or 68 70 4423 4425 O
fondaparinux 71 83 4426 4438 B-treatment
is 84 86 4439 4441 O
allowed 87 94 4442 4449 O

malignancy 0 10 4450 4460 B-treatment
within 11 17 4461 4467 O
3 18 19 4468 4469 B-upper_bound
years 20 25 4470 4475 I-upper_bound
of 26 28 4476 4478 O
study 29 34 4479 4484 O
enrollment 35 45 4485 4495 O

ncontrolled 0 11 4496 4507 B-chronic_disease
hypertension 12 24 4508 4520 I-chronic_disease
, 24 25 4520 4521 O
i.e. 26 30 4522 4526 O
, 30 31 4526 4527 O
blood 32 37 4528 4533 B-clinical_variable
pressure 38 46 4534 4542 I-clinical_variable
( 47 48 4543 4544 I-clinical_variable
BP 48 50 4544 4546 I-clinical_variable
) 50 51 4546 4547 I-clinical_variable
of 52 54 4548 4550 O
≥ 55 56 4551 4552 O
160/95 57 63 4553 4559 B-lower_bound

platelets 0 9 4560 4569 B-clinical_variable
≥ 10 11 4570 4571 O
100,000 12 19 4572 4579 B-lower_bound
/ 19 20 4579 4580 I-lower_bound
uL 20 22 4580 4582 I-lower_bound
( 23 24 4583 4584 O
no 24 26 4584 4586 O
transfusion 27 38 4587 4598 O
allowed 39 46 4599 4606 O
within 47 53 4607 4613 O
2 54 55 4614 4615 B-upper_bound
weeks 56 61 4616 4621 I-upper_bound
) 61 62 4621 4622 O

subjects 0 8 4623 4631 O
who 9 12 4632 4635 O
have 13 17 4636 4640 O
a 18 19 4641 4642 O
history 20 27 4643 4650 O
of 28 30 4651 4653 O
hypertension 31 43 4654 4666 B-chronic_disease
controlled 44 54 4667 4677 O
by 55 57 4678 4680 O
medication 58 68 4681 4691 B-treatment
must 69 73 4692 4696 O
be 74 76 4697 4699 O
on 77 79 4700 4702 O
a 80 81 4703 4704 O
stable 82 88 4705 4711 O
dose 89 93 4712 4716 O

their 0 5 4717 4722 O
partners 6 14 4723 4731 O
must 15 19 4732 4736 O
use 20 23 4737 4740 B-contraception_consent
contraception 24 37 4741 4754 I-contraception_consent
prior 38 43 4755 4760 O
to 44 46 4761 4763 O
study 47 52 4764 4769 O
entry 53 58 4770 4775 O
, 58 59 4775 4776 O
continuing 60 70 4777 4787 O
for 71 74 4788 4791 O
5 75 76 4792 4793 B-upper_bound
months 77 83 4794 4800 I-upper_bound
after 84 89 4801 4806 I-upper_bound
treatment 90 99 4807 4816 B-treatment

total 0 5 4817 4822 B-clinical_variable
bilirubin 6 15 4823 4832 I-clinical_variable
within 16 22 4833 4839 O
normal 23 29 4840 4846 O
range 30 35 4847 4852 O

total 0 5 4853 4858 B-clinical_variable
bilirubin 6 15 4859 4868 I-clinical_variable
≤ 16 17 4869 4870 O
3.0 18 21 4871 4874 B-upper_bound
x 22 23 4875 4876 I-upper_bound
IULN 24 28 4877 4881 I-upper_bound
with 29 33 4882 4886 O
direct 34 40 4887 4893 B-clinical_variable
bilirubin 41 50 4894 4903 I-clinical_variable
within 51 57 4904 4910 O
normal 58 64 4911 4917 O
range 65 70 4918 4923 O
in 71 73 4924 4926 O
subjects 74 82 4927 4935 O
with 83 87 4936 4940 O
Gilbert 88 95 4941 4948 B-chronic_disease
's 95 97 4948 4950 I-chronic_disease
Syndrome 98 106 4951 4959 I-chronic_disease

ventricular 0 11 4960 4971 B-clinical_variable
rate 12 16 4972 4976 I-clinical_variable
less 17 21 4977 4981 O
than 22 26 4982 4986 O
50 27 29 4987 4989 B-upper_bound
beats 30 35 4990 4995 I-upper_bound
/ 35 36 4995 4996 I-upper_bound
min 36 39 4996 4999 I-upper_bound

who 0 3 5000 5003 O
have 4 8 5004 5008 O
not 9 12 5009 5012 O
fully 13 18 5013 5018 O
recovered 19 28 5019 5028 O
from 29 33 5029 5033 O
side 34 38 5034 5038 O
effects 39 46 5039 5046 O
of 47 49 5047 5049 O
such 50 54 5050 5054 O
treatment 55 64 5055 5064 B-treatment

with 0 4 5065 5069 O
the 5 8 5070 5073 O
exception 9 18 5074 5083 O
of 19 21 5084 5086 O
adequately 22 32 5087 5097 O
treated 33 40 5098 5105 O
, 40 41 5105 5106 O
basal 42 47 5107 5112 B-cancer
or 48 50 5113 5115 O
squamous 51 59 5116 5124 B-cancer
cell 60 64 5125 5129 I-cancer
carcinoma 65 74 5130 5139 I-cancer
, 74 75 5139 5140 O
non 76 79 5141 5144 B-cancer
- 79 80 5144 5145 I-cancer
melanomatous 80 92 5145 5157 I-cancer
skin 93 97 5158 5162 I-cancer
cancer 98 104 5163 5169 I-cancer
or 105 107 5170 5172 O
curatively 108 118 5173 5183 O
resected 119 127 5184 5192 O
cervical 128 136 5193 5201 B-cancer
cancer 137 143 5202 5208 I-cancer
or 144 146 5209 5211 O
prior 147 152 5212 5217 O
ovarian 153 160 5218 5225 B-cancer
/ 160 161 5225 5226 O
breast 161 167 5226 5232 B-cancer
cancer 168 174 5233 5239 I-cancer
in 175 177 5240 5242 O
patients 178 186 5243 5251 O
with 187 191 5252 5256 O
BRCA 192 196 5257 5261 O
associated 197 207 5262 5272 O
breast 208 214 5273 5279 O
cancer 215 221 5280 5286 O

within 0 6 5287 5293 O
14 7 9 5294 5296 B-upper_bound
days 10 14 5297 5301 I-upper_bound
prior 15 20 5302 5307 I-upper_bound
to 21 23 5308 5310 O
starting 24 32 5311 5319 O
study 33 38 5320 5325 B-treatment
drug 39 43 5326 5330 I-treatment
or 44 46 5331 5333 O
has 47 50 5334 5337 O
not 51 54 5338 5341 O
recovered 55 64 5342 5351 O
from 65 69 5352 5356 O
major 70 75 5357 5362 O
side 76 80 5363 5367 O
effects 81 88 5368 5375 O

within 0 6 5376 5382 O
either 7 13 5383 5389 O
14 14 16 5390 5392 B-upper_bound
days 17 21 5393 5397 I-upper_bound
or 22 24 5398 5400 O
5 25 26 5401 5402 B-upper_bound
half 27 31 5403 5407 I-upper_bound
- 31 32 5407 5408 I-upper_bound
lives 32 37 5408 5413 I-upper_bound
( 38 39 5414 5415 O
whichever 39 48 5415 5424 O
is 49 51 5425 5427 O
shorter 52 59 5428 5435 O
) 59 60 5435 5436 O
, 60 61 5436 5437 O
prior 62 67 5438 5443 O
to 68 70 5444 5446 O
study 71 76 5447 5452 B-treatment
drug 77 81 5453 5457 I-treatment
administration 82 96 5458 5472 O

≤ 0 1 5473 5474 O
2 2 3 5475 5476 B-upper_bound
weeks 4 9 5477 5482 I-upper_bound
prior 10 15 5483 5488 I-upper_bound
to 16 18 5489 5491 O
starting 19 27 5492 5500 O
study 28 33 5501 5506 B-treatment
drug 34 38 5507 5511 I-treatment

≤ 0 1 5512 5513 O
5 2 3 5514 5515 B-upper_bound
x 4 5 5516 5517 I-upper_bound
IULN 6 10 5518 5522 I-upper_bound
if 11 13 5523 5525 O
liver 14 19 5526 5531 B-cancer
metastases 20 30 5532 5542 I-cancer

≥ 0 1 5543 5544 O
1 2 3 5545 5546 B-lower_bound
cm 4 6 5547 5549 I-lower_bound
on 7 9 5550 5552 O
spiral 10 16 5553 5559 B-treatment
CT 17 19 5560 5562 I-treatment

